WallStreetZenWallStreetZen

NASDAQ: EDIT
Editas Medicine Inc Stock Ownership - Who owns Editas Medicine?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Editas Medicine Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gilmore Neil OneillCEO2026-09-035,124$3.04
$15.56kSell
Amy ParisonCFO;SVP2026-09-03453$3.04
$1.38kSell
Linda BurklyCSci;EVP2026-09-03709$3.04
$2.15kSell
Amy ParisonCFO;SVP2026-08-03678$2.58
$1.75kSell
Linda BurklyCSci;EVP2026-07-284,928$2.67
$13.16kSell
Gilmore Neil OneillCEO2026-06-0315,380$2.70
$41.54kSell
Linda BurklyEVP CHIEF SCIENTIFIC OFFICER2026-06-03731$2.70
$1.97kSell
Amy ParisonSVP Chief Financial Officer2026-06-03464$2.70
$1.25kSell
Gilmore Neil OneillCEO2026-03-035,394$2.02
$10.90kSell
Amy ParisonSVP Chief Financial Officer2026-03-03474$2.02
$957.48Sell

1 of 2

EDIT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EDIT insiders and whales buy or sell their stock.

EDIT Shareholders

What type of owners hold Editas Medicine Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kevin P. Starr2.54%3,906,176$10.16MInsider
Third Rock Ventures III LP2.54%3,906,176$10.16MInsider
Polaris Venture Management Co VI LLC2.47%3,797,144$9.87MInsider
Viking Global Investors LP1.95%2,996,590$7.79MInsider
Kevin Bitterman1.82%2,797,144$7.27MInsider
Flagship Ventures Fund IV LP1.81%2,786,967$7.25MInsider
Boris Nikolic1.75%2,684,572$6.98MInsider
Bng0 LLC1.73%2,649,572$6.89MInsider
James E. Flynn1.18%1,809,400$4.70MInsider
Viking Global Performance LLC0.84%1,287,189$3.35MInsider

1 of 3

EDIT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EDIT0.08%21.44%Net SellingNet Selling
ALT0.08%32.67%Net BuyingNet Selling
ALLO0.09%22.48%Net SellingNet Selling
PRTA0.09%86.09%Net BuyingNet Buying
ASMB0.09%63.98%Net BuyingNet Selling
View Top Biotech Stocks

Editas Medicine Stock Ownership FAQ

Who owns Editas Medicine?

Editas Medicine (NASDAQ: EDIT) is owned by 0.08% institutional shareholders, 21.44% Editas Medicine insiders, and 78.49% retail investors. Kevin P. Starr is the largest individual Editas Medicine shareholder, owning 3.91M shares representing 2.54% of the company. Kevin P. Starr's Editas Medicine shares are currently valued at $10.62M.

If you're new to stock investing, here's how to buy Editas Medicine stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.